Target & Activity
| Target | Activity | Value |
|---|---|---|
| Estrogen receptor | IC50 | 3.3 nM |
| CRISPR/Cas9 |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| DU-145 | EC50 | 10 μM | Antiproliferative activity against human prostate, androgen receptor positive DU145 cells after 24 hrs by MTT assay | [PMID: 25198997] |
| DU-145 | IC50 | 15.3 μM | Antiproliferative activity against human DU-145 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay | [PMID: 33965842] |
| HEK293 | IC50 | 0.07 μM | Antagonist activity at luciferase-fused ERalpha in human HEK293 cells expressing eYFP assessed as reduction of E2-induced estrogenic activity after 2 hrs by BRET assay | [PMID: 26613635] |
| HEK293 | IC50 | 0.79 nM | Antagonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as reduction in E2-induced ER-alpha-mediated transcriptional activity by luciferase reporter gene assay | [PMID: 30940565] |
| Ishikawa | EC50 | 11.5 μM | Antiproliferative activity against human ER-positive Ishikawa cells after 24 hrs by MTT assay | [PMID: 25198997] |
| Ishikawa | IC50 | 3.57 μg/mL | Inhibition of estradiol-induced proliferation in human Ishikawa cells after 72 hrs by Cell-titer-Glo assay | [PMID: 28442256] |
| MCF-10A | IC50 | 10 μM | Cytotoxicity against human MCF10A cells after 72 hrs by MTT assay | [PMID: 25198997] |
| MCF-10A | IC50 | 21.5 μM | Antiproliferative activity against human MCF-10A cells assessed as reduction in cell viability measured after 72 hrs by Cell Counting Kit-8 assay | [PMID: 35611405] |
| MCF7 | IC50 | 0.0034 μM | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 5 days by Coulter counting method | [PMID: 28105283] |
| MCF7 | IC50 | 0.15 μM | Antiproliferative activity against human MCF7 cells treated for 48 hrs followed by refreshed every 96 hrs measured on day 10 by Lowry assay | [PMID: 26613635] |
| MCF7 | IC50 | 0.67 μM | Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by Cell Counting Kit-8 assay | [PMID: 35611405] |
| MCF7 | IC50 | 0.95 μg/mL | Inhibition of estradiol-induced proliferation in human MCF7 cells after 72 hrs by Cell-titer-Glo assay | [PMID: 28442256] |
| MCF7 | IC50 | 10.1 μM | Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay | [PMID: 30939353] |
| MCF7 | IC50 | 15.6 μM | Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay | [PMID: 33965842] |
| MCF7 | IC50 | 17.5 μM | Antiproliferative activity against human MCF7 cells measured after 72 hrs by sulforhodamine B assay | [PMID: 31465222] |
| MCF7 | IC50 | 20 μM | Cytotoxicity against tamoxifen-resistant human MCF7 cells assessed as reduction in cell viability after 5 days by Coulter counting method | [PMID: 28105283] |
| MCF7 | EC50 | 3.5 nM | Antiproliferative activity against human MCF-7 cells incubated for 72 hrs by Cell-titer Glo assay | [PMID: 34251202] |
| MCF7 | EC50 | 7.4 μM | Antiproliferative activity against human ER-negative MCF7 cells after 72 hrs by MTT assay | [PMID: 25198997] |
| MCF7 | EC50 | 8.8 μM | Antiproliferative activity against human ER-negative MCF7 cells after 24 hrs by MTT assay | [PMID: 25198997] |
19 records · Scroll to view more